TNF-α gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 2, 2008, Pages 332-337

  Galiñanes, Manuel ^a   James, Martha ^a   Codd, Veryan ^a   Baxi, Amar ^a   Hadjinikolaou, Leonidas ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Inflammatory reaction; Man; Oxidative stress; TNF polymorphism

Indexed keywords

NICORANDIL; NUCLEOTIDE; PEROXYNITRITE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART SURGERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PERIOPERATIVE COMPLICATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTES; MALE; MIDDLE AGED; NICORANDIL; OXIDATIVE STRESS; PEROXYNITROUS ACID; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 46749111794     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.03.015     Document Type: Article

References (25)

1. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 89 (2001) 763-771
2. Nicola P.J., Maradit-Kremers H., Roger V.L., Jacobsen S.J., Crowson C.S., Ballman K.V., and Gabriel S.E. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52 (2005) 412-420
3. Levine B., Kalman J., Mayer L., Fillit H., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
4. Parker M.M., Shelhammer J.H., Bacharach S.L., Green M.V., Natanson C., Frederick B.A., Damske B.A., and Parrillo J.E. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100 (1984) 483-490
5. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., Glembotski C.C., Quintana P.J., and Sabbadini R.A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid-signalling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
6. Hennein H.A., Ebba H., Rodriguez J.L., Merrick S.H., Keith F.M., Bronstein M.H., Leung J.M., Mangano D.T., Greenfield L.J., and Rankin J.S. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108 (1994) 626-635
7. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195-3199
8. Matata B.M., and Galiñanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg 120 (2000) 1-11
9. Haddad J.J., Saade N.E., and Safieh-Garabedian B. Redox regulation of TNF-alpha biosynthesis: augmentation by irreversible inhibition of gamma-glutamylcysteine synthetase and the involvement of an IkappaB-independent pathway in alveolar epithelial cells. Cell Signal 14 (2002) 211-218
10. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1 (1992) 353
11. Lipsky PE, van der Heijde DM, St Clair EW, Daniel E. Furst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S. Smolen, Michael Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-1602.
12. Shames B.D., Barton H.H., Reznikov L.L., Cairns C.B., Banerjee A., Harken A.H., and Meng X. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 17 (2002) 114-119
13. Dörge H., Schulz R., Belosjorow S., Post H., van de Sand A., Konietzka I., Frede S., Hartung T., Vinten-Johansen J., Youker K.A., Entman M.L., Erbel R., and Heusch G. Coronary microembolization: the role of TNF-α in contractile dysfunction. J Mol Cell Cardiol 34 (2002) 51-62
14. Maekawa N., Wada H., Kanda T., Niwa T., Yamada Y., Saito K., Fujiwara H., Sekikawa K., and Seishima M. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α. J Am Coll Cardiol 39 (2002) 1229-1235
15. Gurevitch J., Frolkis I., Yuhas Y., Lifschitz-Mercer B., Berger E., Paz Y., Matsa M., Kramer A., and Mohr R. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30 (1997) 1554-1561
16. Dawn B., Guo Y., Rezazadeh A., Wang O.L., Stein A.B., Hunt G., Varma J., Xuan Y.T., Wu W.J., Tan W., Zhu X., and Bolli R. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37 (2004) 51-61
17. Tuglular S., Berthoux P., and Berthoux F. Polymorphyisms of the tumor necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 18 (2003) 724-731
18. Appoloni O., Dupont E., Vandercruys M., Andrien M., Duchateau J., and Vincent J.L. Association between the TNF-2 allele and a better survival in cardiogenic shock. Chest 125 (2004) 2232-2237
19. Whyte M., Hubbard R., Meliconi R., Whidborne M., Eaton V., Bingle C., Timms J., Duff G., Facchini A., Pacilli A., Fabbri M., Hall I., Britton J., Johnston I., and Di Giovine F. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms. Am J Respir Crit Care Med 162 (2000) 755-758
20. 2+ overload in rat heart mitochondria. J Physiol 519 Pt 2 (1999) 347-360
21. Pain T., Yang X.M., Critz S.D., Yue Y., Nakano A., Liu G.S., Heusch G., Cohen M.V., and Downey J.M. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 87 (2000) 460-466
22. Andrukhiv A., Costa A.D., West I.C., and Garlid K.D. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 29 (2006) H2067-H2074
23. Ozcan C., Bienengraeber M., Dzeja P.P., and Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 282 (2002) H531-H539
24. Ghosh S., Standen N.B., and Galiñanes M. Evidence for mitochondrial KATP channels as effectors of human myocardial preconditioning. Cardiovasc Res 45 (2000) 934-940
25. Loubani M., and Galiñanes M. Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels. J Thorac Cardiovasc Surg 124 (2002) 750-757